Disc Medicine (IRON) Tops Q3 EPS by 14c

Disc Medicine (NASDAQ: IRON) reported Q3 EPS of ($0.89), $0.14 better than the analyst estimate of ($1.03).

For earnings history and earnings-related data on Disc Medicine (IRON) click here.

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Madison Square Garden Sports Corp. (MSGS) Tops Q4 EPS by 62c
• Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance